Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.79 BRL | -3.48% | -12.57% | +173.18% |
Apr. 18 | Biocon Signs Licensing and Supply Pact with Biomm to Commercialize Generic Ozempic in Brazil | MT |
Apr. 17 | Biocon Limited Signs an Exclusive Licensing and Supply Agreement with Biomm S.A | CI |
Sales 2022 | 105M 20.44M | Sales 2023 | 118M 23.02M | Capitalization | 470M 91.51M |
---|---|---|---|---|---|
Net income 2022 | -92M -17.92M | Net income 2023 | -81M -15.78M | EV / Sales 2022 | 5.9 x |
Net Debt 2022 | 67.72M 13.19M | Net Debt 2023 | 125M 24.33M | EV / Sales 2023 | 5.03 x |
P/E ratio 2022 |
-5.37
x | P/E ratio 2023 |
-5.93
x | Employees | 130 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 47.6% |
1 day | -0.44% | ||
1 week | -12.57% | ||
Current month | -21.79% | ||
1 month | +40.36% | ||
3 months | +190.26% | ||
6 months | +181.46% | ||
Current year | +173.18% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Director of Finance/CFO | - | 19-04-15 | |
Luciano Vilela
CTO | Chief Tech/Sci/R&D Officer | - | 14-02-19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 14-01-31 | |
Director/Board Member | 84 | 15-10-12 | |
Director/Board Member | 81 | 13-12-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 15.79 | -0.44% | 137,400 |
24-05-14 | 15.86 | -6.15% | 211,500 |
24-05-13 | 16.9 | -6.11% | 108,500 |
24-05-10 | 18 | 0.00% | 217,600 |
24-05-09 | 18 | -0.33% | 26,400 |
Delayed Quote Sao Paulo, May 15, 2024 at 04:07 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+173.18% | 275M | |
+7.52% | 113B | |
+11.38% | 106B | |
-12.64% | 22.22B | |
+0.44% | 22.27B | |
-4.18% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+37.41% | 12.52B | |
-23.95% | 8.34B |
- Stock Market
- Equities
- BIOM3 Stock